The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Expected Market Value Outlook For The Single Nucleotide Polymorphism (SNP) Genotyping Market Through 2030?
The single nucleotide polymorphism (snp) genotyping market has seen substantial growth in recent years. It is anticipated to increase from $12.34 billion in 2025 to $14.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 19.1%. The historical expansion of this market can be attributed to elements such as limited early-stage genotyping capabilities, growing demand in research, high cost of genomic analysis, rising collaboration between research labs, and early adoption in pharmacogenomics.
The single nucleotide polymorphism (snp) genotyping market size is projected for significant expansion over the coming years. By 2030, this market is anticipated to reach a valuation of $29.74 billion, expanding at a compound annual growth rate (CAGR) of 19.3%. This projected growth is driven by several factors, including the advancement of high-throughput SNP platforms, broader uptake in personalized medicine, the incorporation of AI for predictive analysis, its expansion into clinical diagnostics, and the rise of its use in agricultural genomics applications. Key trends expected during the forecast period encompass its integration with pharmacogenomics, an increase in disease risk prediction applications, wider utilization in agriculture and animal breeding, the embrace of microarray-based genotyping, and the emergence of point-of-care SNP testing.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12569&type=smp
Which Strategic Drivers Are Supporting The Single Nucleotide Polymorphism (SNP) Genotyping Market Development?
The increasing burden of chronic conditions is anticipated to drive the expansion of the single nucleotide polymorphism (SNP) genotyping market moving forward. Chronic conditions are health issues that persist for a year or longer, demanding continuous medical care, restricting daily activities, or both. The escalating prevalence of chronic diseases makes single-nucleotide polymorphism (SNP) genotyping vital for identifying genetic predispositions and fostering personalized medicine. For example, the Centers for Disease Control and Prevention (CDC), a US-based federal agency, indicated in April 2025 that in 2023, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. As a result, the growing impact of chronic conditions is a primary factor fueling the growth of the single nucleotide polymorphism (SNP) genotyping systems market.
What Segment Types Are Included In The Single Nucleotide Polymorphism (SNP) Genotyping Market Analysis?
The single nucleotide polymorphism (snp) genotyping market covered in this report is segmented –
1) By Product: Consumables, Instruments, Services
2) By Technology: TaqMan SNP Genotyping, Mass Array SNP Genotyping, SNP Gene Chip Arrays, Other Technologies
3) By Application: Animal Genetics, Plant Improvement, Diagnostic Research, Pharmaceuticals And Pharmacogenomics, Agricultural Biotechnology, Other Applications
Subsegments:
1) By Consumables: Reagents And Kits, DNA Probes, Microarrays
2) By Instruments: SNP Genotyping Platforms, Sequencers, PCR Machines
3) By Services: SNP Genotyping Services, Data Analysis Services, Consultation Services
Which Trends Are Supporting The Evolution Of The Single Nucleotide Polymorphism (SNP) Genotyping Market?
Leading companies in the single-molecule real-time sequencing market are concentrating on developing sophisticated solutions, such as benchtop long-read sequencers that offer high-fidelity read output, to gain a competitive edge. A benchtop long-read sequencer is defined as a compact laboratory instrument that facilitates long-read DNA sequencing with high accuracy and reasonable throughput, making advanced sequencing available outside large genome centers. For instance, in November 2024, Pacific Biosciences, a US-based genomics company, introduced the Vega benchtop sequencer. This device delivers up to 60 gigabases per run, generates highly accurate long reads (HiFi), and supports genomic, transcriptomic, and epigenetic data creation in small labs. These capabilities broaden the user base, accelerate its adoption in clinical and research labs, and reduce barriers to entry. However, smaller labs might still encounter cost limitations for routine application.
Which Companies Are Engaged In The Single Nucleotide Polymorphism (SNP) Genotyping Market Environment?
Major companies operating in the single nucleotide polymorphism (snp) genotyping market are Thermo Fischer Scientific Inc, Danaher Corporation, Roche Diagnostics Corporation, GE HealthCare Technologies Inc, Eurofins Genomics LLC, Beckman Coulter Inc, Bio-Rad Laboratories Inc, Qiagen N.V, Sigma-Aldrich Corporation, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Promega Corporation, GenScript Biotech Corporation, Integrated DNA Technologies Inc, LGC Ltd, Sequenom Inc, Fluidigm Corporation, Oxford Gene Technology, Affymetrix Inc, PREMIER Biosoft International Inc, Rubicon Genomics, Xcelris Genomics, Douglas Scientific LLC, Golden Helix Inc
Access The Complete Single Nucleotide Polymorphism (SNP) Genotyping Market Report:
Which Region Commands The Largest Share Of The Single Nucleotide Polymorphism (SNP) Genotyping Market?
North America was the largest region in the single nucleotide polymorphism (SNP) genotyping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single nucleotide polymorphism (snp) genotyping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Single Nucleotide Polymorphism (SNP) Genotyping Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=12569&type=smp
Browse Through More Reports Similar to the Global Single Nucleotide Polymorphism (SNP) Genotyping Market 2026, By The Business Research Company
Genotyping Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report
Genotyping Assay Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report
Genomics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/genomics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model